Key takeaways
Otezla (apremilast) and Enbrel (etanercept) are both used to treat autoimmune conditions, but they have some key differences. Otezla is a tablet taken daily, while Enbrel is given as an injection. Otezla is available in a generic form, but it likely won't be on the market until at least 2028, whereas Enbrel is only available as a brand-name product and can be expensive. Otezla is used for conditions like psoriasis, psoriatic arthritis, and Behçet’s disease, while Enbrel treats rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and childhood arthritis. Otezla can cause side effects like nausea, diarrhea, and weight loss, while Enbrel can increase the risk of serious infections and certain cancers.
Prices with our coupons for Otezla vs. Enbrel
Compare other Plaque Psoriasis and Psoriatic Arthritis drugs
Methotrexate vs. OtezlaOtezla vs. CosentyxOtezla vs. EnbrelOtezla vs. HumiraRinvoq vs. Otezla
Skyrizi vs. OtezlaSotyktu vs. OtezlaTaltz vs. OtezlaTremfya vs. OtezlaXeljanz vs. OtezlaBimzelx vs. CosentyxChloroquine vs. MethotrexateCosentyx vs. CimziaCosentyx vs. HumiraCosentyx vs. TaltzCosentyx vs. TremfyaDuobrii vs. CosentyxEnbrel vs. CosentyxEnbrel vs. HumiraEnbrel vs. SimponiEnbrel vs. TrexallEnbrel vs. XeljanzHumira vs. MethotrexateMethotrexate vs. AravaMethotrexate vs. PlaquenilMethotrexate vs. SulfasalazineRinvoq vs. CosentyxSkyrizi vs. CosentyxStelara vs. CosentyxTremfya vs. Cosentyx
